Abstract:
Solid lipid nanoparticles (SLNs) technology represents a promising new approach to lipophilic drug delivery. Solid lipid nanoparticles are
important advancement in this area. The biodegradable and bioacceptable nature of SLNs makes them less toxic as compared to polymeric
nanoparticles. SLNs can also be used to improve the bioavalability of drugs. In this present review this new approach is discussed in terms
of their advantages, characterization, in-vivo studies, in-vitro studies, pharmacokinetic studies and special features.
